Stock Alert: Vir Biotechnology Shares Soar 26% In Pre-Market

Shares of Vir Biotechnology Inc. (VIR) are rising over 26% in pre-market today, after the company announced signing of a binding agreement to enter into a collaboration with GlaxoSmithKline plc (GSK) to research and develop solutions for coronaviruses, including SARS-CoV-2, the virus that causes COVID-19.